Asthma Clinical Trial
Official title:
A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency Department
The primary idea is that the use of a computerized reminder system to help with the guideline
implementation will increase utilization and adherence of guideline-driven care, leading to
improved patient outcomes. The hypothesis we aim to address is that an automatic,
computerized reminder system for detecting asthma patients in the pediatric ED will increase
paper-based guideline utilization compared to paper-based guideline without the system.
We aim to implement a real-time, computerized asthma detection system and integrate the
system with the pediatric emergency department information system, and evaluate the effect of
the asthma detection system on reminding clinicians to use the paper-based asthma guideline.
Asthma is the leading chronic childhood disease affecting 9 million children (12.5%) under 18
years of age (1). Asthma exacerbations cause an estimated 14 million missed school days (2)
and more than 1.8 million emergency department (ED) visits annually (2), and account for >60%
of asthma-related costs (3). The chronic characteristic of asthma carries a considerable
economic burden.
Uncontrolled asthma can lead to exacerbations requiring the patient to seek immediate care,
frequently in an ED setting. Several asthma guidelines, including the nationally accepted
guideline from the National Heart, Lung, and Blood Institute (NHLBI), exist to support
clinicians in providing adequate treatment. Utilization of and adherence with asthma
guidelines improves patients' clinical care (4, 5). However, guideline adherence remains
suboptimal. In the ED, early recognition and accurate assessment of the severity of airway
obstruction and response to therapy are fundamental to the improvement of health for patients
with asthma. The NHLBI guidelines emphasize early recognition and treatment of asthma
exacerbations, as well as appropriate treatment stratified by severity.
Computer applications for patient care can address barriers to optimal medical care. Computer
systems have improved the use and adherence to practice guidelines, provide clinical alerts
and reminders, and generate patient-specific treatment recommendations and educational
material. Implementation of guideline-driven decision support is frequently paper-based or
computerized. In either form a major barrier remains on the busy clinicians to remember to
initiate the guideline a process and to embed the guideline tasks in the clinical workflow of
the care team (5). The proposed study examines the benefits of a novel approach for reminding
clinicians in an ED setting to use guideline-driven care. The approach will apply a
workflow-embedded process taking advantage of an advanced information technology
infrastructure. The informatics approach will include two elements: a) a computerized,
real-time reminder system, which will automatically detect guideline-eligible patients
without requiring additional data entry, and b) a computerized, workflow-embedded guideline
implementation.
References
1. Ref: QuickStats: Percentage of Children Aged <18 years Who Have Ever Had Asthma
Diagnosed, by Age Group --- United States, 2003; MMWR April 29, 2005 / 54(16);412.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5416a5.htm
2. Allergy & Asthma Advocate. Quarterly patient newsletter of the American Academy of
Allergy, Asthma and immunology. 2004.
3. Grimshaw JM, Eccles MP, Walker AE, Thomas RE. Changing physicians' behavior: what works
and thoughts on getting more things to work. J Contin Educ Health Prof. 2002;22:237-243.
4. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention
Program. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma.
1997.
5. Scribano PV, Lerer T, Kennedy D, Cloutier MM. Provider adherence to a clinical practice
guideline for acute asthma in a pediatric emergency department. Acad Emerg Med.
2001;8:1147-1152.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|